HCV research and anti-HCV drug discovery: Toward the next generation

Advanced Drug Delivery Reviews

Volumn 59, Issue 12, 2007, Pages 1196-1199

  Wakita, Takaji ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Anti viral drug; Hepatitis C virus; Interferon; Replicon; Ribavirin; Vaccine; Virus culture

Indexed keywords

BIOLOGICAL ORGANS; CELLS; DISEASES; DRUG PRODUCTS; GENES; INTERFERONS;

HEPATOCELLULAR CARCINOMA; REPLICON SYSTEMS; RIBAVIRIN; VIRUS CULTURE;

VIRUSES;

ALPHA INTERFERON; ANTIVIRUS AGENT; COMPLEMENTARY DNA; HEPATITIS C VACCINE; NEUTRALIZING ANTIBODY; RIBAVIRIN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; DRUG RESEARCH; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIFE CYCLE; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CULTURE; VIRUS HEPATITIS; VIRUS REPLICATION;

EID: 35648939730     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.08.021     Document Type: Note

References (42)

1. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 244 (1989) 359-362
2. Kuo G., Choo Q.L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., Tegtmeier G.E., Bonino F., Colombo M., Lee W.-S., Kuo C., Berger K., Shuster J.R., Overby L.R., Bradley D.W., and Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science 244 (1989) 362-364
3. Hoofnagle J.H., Mullen K.D., Jones D.B., Rustgi V., Di Bisceglie A., Peters M., Waggoner J.G., Park Y., and Jones E.A. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N. Engl. J. Med. 315 (1986) 1575-1578
4. Chevaliez S., and Pawlotsky J.-M. Interferon-based therapy of hepatitis C. Adv. Drug Deliv. Rev. (2007)
5. Bartenschlager R., and Lohmann V. Novel cell culture systems for the hepatitis C virus. Antivir. Res. 52 (2001) 1-17
6. Kaplan G., and Racaniello V.R. Construction and characterization of poliovirus subgenomic replicons. J. Virol. 62 (1988) 1687-1696
7. Khromykh A.A., and Westaway E.G. Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 71 (1997) 1497-1505
8. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (1999) 110-113
9. Blight K.J., Kolykhalov A.A., and Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science 290 (2000) 1972-1974
10. Lohmann V., Korner F., Dobierzewska A., and Bartenschlager R. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 75 (2001) 1437-1449
11. Krieger N., Lohmann V., and Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75 (2001) 4614-4624
12. Ikeda M., Yi M., Li K., and Lemon S.M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 76 (2002) 2997-3006
13. Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., Strand D., and Bartenschlager R. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol. 76 (2002) 4008-4021
14. Blight K.J., McKeating J.A., Marcotrigiano J., and Rice C.M. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J. Virol. 77 (2003) 3181-3190
15. Bukh J., Pietschmann T., Lohmann V., Krieger N., Faulk K., Engle R.E., Govindarajan S., Shapiro M., St.Claire M., and Bartenschlager R. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14416-14421
16. Kolykhalov A.A., Agapov E.V., Blight K.J., Mihalik K., Feinstone S.M., and Rice C.M. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277 (1997) 570-574
17. Yanagi M., Purcell R.H., Emerson S.U., and Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 8738-8743
18. Tanaka T., Kato N., Cho M.J., and Shimotohno K. A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem. Biophys. Res. Commun. 215 (1995) 744-749
19. Mercer DF.A., Schiller D.E., Elliott J.F., Douglas D.N., Hao C., Rinfret A., Addison W.R., Fischer K.P., Churchill T.A., Lakey J.R., Tyrrell D.L., and Kneteman N.M. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7 (2001) 927-933
20. Cohen J. Culture system for hepatitis C virus in sight at last. Science 308 (2005) 1539-1541
21. Kato T., Furusaka A., Miyamoto M., Date T., Yasui K., Hiramoto J., Nagayama K., Tanaka T., and Wakita T. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 64 (2001) 334-339
22. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., and Wakita T. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterol. 125 (2003) 1808-1817
23. Uprichard S.L., Chung J., Chisari F.V., and Wakita T. Replication of a hepatitis C virus replicon clone in mouse cells. Virol. J. 3 (2006) 89
24. T. Date, M. Miyamoto, T. Kato, K. Morikawa, A. Murayama, D. Akazawa, J. Tanabe, S. Sone, M. Mizokami, T. Wakita, An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain. Hepatol. Res. in press.
25. Kato T., Date T., Miyamoto M., Sugiyama M., Tanaka Y., Orito E., Ohno T., Sugihara K., Hasegawa I., Fujiwara K., Ito K., Ozasa A., Mizokami M., and Wakita T. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J. Clin. Microbiol. 43 (2005) 5679-5684
26. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
27. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9294-9299
28. Blight K.J., McKeating J.A., and Rice C.M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76 (2002) 13001-13014
29. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
30. Yi M., Villanueva R.A., Thomas D.L., Wakita T., and Lemon S.M. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2310-2315
31. Kanda T., Basu A., Steele R., Wakita T., Ryerse J.S., Ray R., and Ray R.B. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol. 80 (2006) 4633-4639
32. Cai Z., Zhang C., Chang K.-Y., Jiang J., Ahn B.-C., Wakita T., Liang J.T., and Luo G. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J. Virol. 79 (2005) 13963-13973
33. Kato T., Matsumura T., Heller T., Saito S., Sapp R.K., Murthy K., Wakita T., and Liang T.J. Production of infectious hepatitis C virus of various genotypes in cell culture. J. Virol. (2007) ([Epub ahead of print])
34. Koutsoudakis G., Kaul A., Steinmann E., Kallis S., Lohmann V., Pietschmann T., and Bartenschlager R. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80 (2006) 5308-5320
35. K. Morikawa, Z. Zhao, T. Date, M. Miyamoto, A. Murayama, D. Akazawa, J. Tanabe, S. Sone, T. Wakita, The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. J Med Virol. in press.
36. Kapadia S.B., Barth H., Baumert T., McKeating J.A., and Chisari F.V. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81 (2007) 374-383
37. Grove J., Huby T., Stamataki Z., Vanwolleghem T., Meuleman P., Farquhar M., Schwarz A., Moreau M., Owen J.S., Leroux-Roels G., Balfe P., and McKeating J.A. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J. Virol. (2007) ([Epub ahead of print])
38. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., and Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature (2007) ([Epub ahead of print])
39. Blanchard E., Belouzard S., Goueslain L., Wakita T., Dubuisson J., Wychowski C., and Rouillé Y. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 80 (2006) 6964-6972
40. Shirakura M., Murakami K., Ichimura T., Suzuki R., Shimoji T., Fukuda K., Abe K., Sato S., Fukasawa M., Yamakawa Y., Nishijima M., Moriishi K., Matsuura Y., Wakita T., Suzuki T., Howley P.M., Miyamura T., and Shoji I. The E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J. Virol. 81 (2007) 1174-1185
41. Houghton M., and Abrignani S. Prospects for a vaccine against the hepatitis C virus. Nature 436 (2005) 961-966
42. Meunier J.C., Engle R.E., Faulk K., Zhao M., Bartosch B., Alter H., Emerson S.U., Cosset F.L., Purcell R.H., and Bukh J. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4560-4565